ALPROLIX is a recombinant DNA derived, coagulation Factor IX concentrate indicated in adults and children with hemophilia B for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
- On-demand treatment and control of bleeding episodes
- Perioperative management of bleeding
- Routine prophylaxis to reduce the frequency of bleeding episodes
Limitation of Use: ALPROLIX is not indicated for induction of immune tolerance in patients with hemophilia B. See Important Safety Information.
Limitation of Use: ALPROLIX is not indicated for induction of immune tolerance in patients with hemophilia B. See Important Safety Information.
†ALPROLIX has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.1
‡ALPROLIX prophylaxis provides comparable or reduced number of injections vs SHLs, which may help reduce treatment burden for patients.1,2
EHL=extended half-life; PTP=previously treated patient; PUP=previously untreated patient; SHL=standard half-life.